Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Articulate Biosciences

Articulate Biosciences?uq=K9LEA9hy
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
$15K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of injectable viscoelastic gels designed for the treatment of arthritis and other soft tissue diseases. The company's gel utilizes tissue-protecting and function-restoring biomedical polymers that helps in eliminating chronic joint pain, enabling patients suffering from osteoarthritis to get relieve from pain and restore mobility.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Discovery
Primary Office
  • 110 Canal Street
  • 4th floor
  • Lowell, MA 01852
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Articulate Biosciences’s full profile, request a free trial.

Articulate Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Jan-2018 $15K Completed Startup
1. Grant 01-Aug-2017 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Articulate Biosciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0

Articulate Biosciences Executive Team (2)

Name Title Board
Seat
Contact
Info
Benjamin Cooper Co-Founder & Chief Executive Officer
Mark Grinstaff Ph.D Co-Founder